NCT00001341 2008-03-04A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic DiseaseNational Institutes of Health Clinical Center (CC)Phase 1 Completed60 enrolled